Summary of Significant Accounting Policies (Tables)
|
6 Months Ended |
12 Months Ended |
Jun. 30, 2026 |
Dec. 31, 2025 |
| Summary of Significant Accounting Policies [Abstract] |
|
|
| Schedule of Allowance for Credit Losses |
|
Activity related to the Company’s allowance for credit losses during the years ended December 31, 2025 and 2024 was as follows: | | | 2025 | | | 2024 | | | Allowance for credit losses, beginning balance | | $ | 223,166 | | | $ | 48,166 | | | Credit loss provision | | | 8,800,602 | | | | 176,307 | | | Write-offs | | | - | | | | (1,307 | ) | | Allowance for credit losses, ending balance | | $ | 9,023,768 | | | $ | 223,166 | |
|
| Schedule of Inventory |
The table below presents the Company’s inventory values, by category, as of June 30, 2026 and December 31, 2025: | | | June 30,
2026 | | | December 31,
2025 | | | Raw materials | | $ | 35,643 | | | $ | 251,911 | | | Finished goods | | | 4,676,132 | | | | 2,625,249 | | | Total net realizable value | | $ | 4,711,775 | | | $ | 2,877,160 | |
|
The table below presents the Company’s inventory values, by category, as of December 31, 2025 and 2024: | | | 2025 | | | 2024 | | | Raw materials | | $ | 251,911 | | | $ | 176,218 | | | Finished goods | | | 2,625,249 | | | | 1,647,784 | | | Total net realizable value | | $ | 2,877,160 | | | $ | 1,824,001 | |
|
| Schedule of Estimated Useful Lives |
|
Depreciation expense commences once a PP&E asset is ready for its intended use and is computed using the straight-line method based on the estimated useful lives of the related assets as follows: | Category | | Estimated Useful Life | | Land | | Infinite (not depreciated) | | Building and Building Improvements | | 3-39 years | | Machinery and Equipment | | 3-7 years | | Computer and Office Equipment | | 3 years | | Furniture and Fixtures | | 5-7 years | | Construction-in-Process | | Not depreciated until placed into service |
|
| Schedule of Amortization of Intangible Assets with Finite Lives |
|
Amortization of intangible assets with finite lives is calculated on the straight-line method based on the following estimated useful lives: | Website and software development costs | | | 5 years | | | Intellectual property | | | 5 years | | | Customer relationships | | | 7 years | |
|
| Schedule of Revenue Disaggregated by Major Products Categories |
The following table provides information about revenue disaggregated by major sites of service: | | | Three Months Ended
June 30, | | | Six Months Ended
June 30, | | | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | Hospital | | $ | 6,712,240 | | | $ | - | | | $ | 12,076,119 | | | $ | - | | | Physician office | | | 1,098,449 | | | | 10,963,174 | | | | 1,870,100 | | | | 26,930,195 | | | Other | | | 88,560 | | | | - | | | | 88,560 | | | | - | | | Revenue, net | | $ | 7,899,249 | | | $ | 10,963,174 | | | $ | 14,034,779 | | | $ | 26,930,195 | |
|
The following table provides information about revenue disaggregated by major products categories: | | | For the years ended | | | | | December 31, | | | | | 2025 | | | 2024 | | | VendajeAC | | $ | 44,045,014 | | | $ | 10,617,897 | | | Amnio Wrap 2 | | | 3,348,726 | | | | 58,783,096 | | | Other | | | 88,275 | | | | 257,427 | | | Revenue, net | | $ | 47,482,015 | | | $ | 69,658,420 | |
|
| Schedule of Basic and Dilutive Earnings Per Share |
Basic and dilutive net (loss) income per share is as follows: | | | Three Months Ended
June 30, | | | Six Months Ended
June 30, | | | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | Net (loss) income available to common shareholders (numerator) | | $ | (8,971,360 | ) | | $ | 10,613 | | | $ | (17,791,065 | ) | | $ | 3,918,735 | | | | | | | | | | | | | | | | | | | | | Weighted-average number of common shares (denominator) | | | 17,327,652 | | | | 16,708,776 | | | | 17,090,140 | | | | 16,689,537 | | | | | | | | | | | | | | | | | | | | | Basic (loss) income per common share | | $ | (0.52 | ) | | $ | 0.00 | | | $ | (1.04 | ) | | $ | 0.23 | | | | | | | | | | | | | | | | | | | | | Weighted-average number of common shares | | | 17,327,652 | | | | 16,708,776 | | | | 17,090,140 | | | | 16,689,537 | | | Potential shares of common stock arising from stock options, warrants, and unvested RSU’s | | | - | | | | 6,710,950 | | | | - | | | | 6,818,731 | | | Total shares-diluted (denominator) | | | 17,327,652 | | | | 23,419,726 | | | | 17,090,140 | | | | 23,508,268 | | | | | | | | | | | | | | | | | | | | | Diluted (loss) income per common share | | $ | (0.52 | ) | | $ | 0.00 | | | $ | (1.04 | ) | | $ | 0.17 | | | | | | | | | | | | | | | | | | | | | Anti-dilutive weighted shares excluded from the calculation of diluted (loss) income per common share | | | 5,312,033 | | | | 58,800 | | | | 6,236,531 | | | | 51,370 | |
|
Basic and dilutive earnings per share is as follows: | | | 2025 | | | 2024 | | | Net (loss) income available to common shareholders (numerator) | | $ | (6,580,912 | ) | | $ | 31,030,713 | | | | | | | | | | | | | Weighted-average number of common shares (denominator) | | | 16,728,783 | | | | 16,368,429 | | | | | | | | | | | | | Basic (loss) earnings per common share | | $ | (0.39 | ) | | $ | 1.90 | | | | | | | | | | | | | Weighted-average number of common shares | | | 16,728,783 | | | | 16,368,429 | | | Potential shares of common stock arising from stock options, warrants, and unvested RSU’s | | | - | | | | 5,329,956 | | | Total shares-diluted (denominator) | | | 16,728,783 | | | | 21,698,384 | | | | | | | | | | | | | Diluted (loss) earnings per common share | | $ | (0.39 | ) | | $ | 1.43 | | | | | | | | | | | | | Anti-dilutive weighted shares excluded from the calculation of earnings per common share | | | 6,672,524 | | | | - | |
|